Treatment escalation vs. immediate initiation of highly effective treatment for patients with relapsing-remitting multiple sclerosis: data from 2 different national strategies.
22 Aug, 2021 | 22:06h | UTCTreatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies – JAMA Neurology (free for a limited period)
Commentary on Twitter
Study suggests that escalation of #multiplesclerosis treatment was inferior to initial treatment with a more effective disease-modifying agent https://t.co/hkHsAXP5se
— JAMA Neurology (@JAMANeuro) August 16, 2021